TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
PharmaLogic Consulting AB
Closing information (x1000 DKK)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
3,047
|
140 | |
| Financial expenses |
0
|
155 | |
| Earnings before taxes |
2,334
|
-831 | |
| EBITDA |
2,270
|
-677 | |
| Total assets |
6,606
|
6,031 | |
| Current assets |
5,519
|
4,918 | |
| Current liabilities |
775
|
229 | |
| Equity capital |
5,788
|
5,480 | |
| - share capital |
32
|
34 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
87.6%
|
90.9% | |
| Turnover per employee |
3,047
|
140 | |
| Profit as a percentage of turnover |
76.6%
|
-593.6% | |
| Return on assets (ROA) |
35.3%
|
-11.2% | |
| Current ratio |
712.1%
|
2147.6% | |
| Return on equity (ROE) |
40.3%
|
-15.2% | |
| Change turnover |
2,913
|
-1,725 | |
| Change turnover % |
-95%
|
2180%
|
-92% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.